Drug Profile
Sumatriptan transmucosal - Targia Pharmaceuticals
Alternative Names: Omexa; Omexa SumatriptanLatest Information Update: 21 Oct 2021
Price :
$50
*
At a glance
- Originator Targia Pharmaceuticals
- Developer SoluBest; Targia Pharmaceuticals
- Class Antimigraines; Indoles; Small molecules; Sulfonamides; Tryptamines
- Mechanism of Action 5-HT1 serotonin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Migraine
Most Recent Events
- 28 Apr 2019 No recent reports of development identified for phase-I development in Migraine(In volunteers) in Israel (Sublingual, Tablet)